Key facts
- This page summarizes Robert Weinstein's Form 3 filing for Petros Pharmaceuticals, Inc. (PTPI).
- 0 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 25 Jun 2026, 17:00.
Key filing fact
Ownership activity is grounded in SEC Form 3 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
No transaction description listed
Additional SEC filing notes
Footnote F1
Includes (i) 6,004 restricted shares of common stock, par value $0.0001, of the Issuer, of which 3,004 shares are vested and the remainder of which will vest on February 2, 2027, (ii) 315,000 vested restricted stock units ("RSUs"), and (iii) 315,000 unvested RSUs, 2,500 of which will vest on July 2, 2026 and the remainder of which will vest on December 5, 2026.